Zobrazeno 1 - 9 of 9 pro vyhledávání: '"Masako Fukami"'
1
Autoimmune neutropenia due to antineutrophil antibodies in a patient with primary sclerosing cholangitis
Autor: Yoshiyuki Fujita, Takashi Sato, Hajime Takikawa, Ryo Miura, Masako Fukami, Hideaki Goto, Yoriyuki Takamori, Masao Kobayashi, Atsushi Tanaka, Naoko Hanawa, Haruko Tashiro, Hiroshi Kawaguchi, Mitsuhiko Aiso
Publikováno v: Clinical Journal of Gastroenterology. 3:149-154
Autoimmune neutropenia (AIN) is defined as a decrease in the circulating absolute neutrophil count (ANC) to less than 1500/μl caused by serum antineutrophil antibodies. Secondary AIN is associated with various autoimmune diseases. Herein we present
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e271077b0908e7789eb878787358d367
https://doi.org/10.1007/s12328-010-0145-1
Zobrazit plný text záznamu
3
Gastroduodenal mucosal injury in patients on antiplatelet therapy
Autor: Masaki Sanaka, Kunitaka Nagasawa, Taro Ishii, Masako Fukami, Koichiro Abe, Takatsugu Yamamoto, Yasushi Kuyama, Akihiko Tsuchiya, Shin Nakayama
Publikováno v: Thrombosis Research. 120:465-469
It is widely accepted that antiplatelet agents (APs)such as aspirin (Asp) have certain preventive effectsagainst cerebral and cardiovascular events inpatients with atherothrombotic disease [1].Recentclinicaltrialshaveshownthatthisbeneficialefficacyco
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ee9744aaff971f2924f3b5b7798dceb
https://doi.org/10.1016/j.thromres.2006.12.010
Zobrazit plný text záznamu
4
Indirect immunofluorescence and ELISA for testing of antimitochondrial antibodies -Which is better?
Autor: Toshiaki Nakano, Yasuni Nakanuma, Masako Fukami, Hajime Takikawa, Junko Hirohara, Hirohito Tsubouchi, Atsushi Tanaka, Ryo Miura, Yoriyuki Takamori, Hiroshi Miyakawa
Publikováno v: Kanzo. 51:531-533
For Antimitochondrial antibodies (AMA) testing, both indirect immunofluorescense (IF) and ELISA (M2) are currently used. Herein we aimed to suggest which is better for AMA testing in clinical setting. Recent nation-wide surveillances for PBC demonstr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::026b820ec8ea0b18cd74ff4e65d29095
https://doi.org/10.2957/kanzo.51.531
Zobrazit plný text záznamu
5
A study on dividing doses of ursodeoxycholic acid (UDCA) for patients with chronic hepatitis C
Autor: Masako Fukami, Ryo Miura, Hideaki Goto, Masaki Mikami, Hajime Takikawa, Satoko Uegaki, Yoshihiko Morisawa, Mitsuhiko Aiso, Atsushi Tanaka, Shinichiro Negoro, Naoko Hanawa
Publikováno v: Kanzo. 48:559-561
We studied whether the frequency of daily dosing of ursodeoxycholic acid (UDCA) affects its efficacy in patients with chronic hepatitis C. Twenty-nine patients with chronic hepatitis C having received UDCA (600mg) three times a day were randomized to
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0aea5bfb80cf4837f3e573fc8b203bd5
https://doi.org/10.2957/kanzo.48.559
Zobrazit plný text záznamu
6
Effect of penicillin G on the biliary excretion of cholephilic compounds in rats
Autor: Hajime Takikawa, Atsushi Tanka, Masako Fukami
Publikováno v: Journal of hepato-biliary-pancreatic sciences. 18(5)
Penicillin G is reported to increase bile flow by increasing biliary glutathione excretion, as well as the biliary excretion of penicillin G itself. In order to study the effect of penicillin G on the hepatic excretory pathway, the effect of colchici
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbc348f3a8869362000e684a5f44b225
https://pubmed.ncbi.nlm.nih.gov/21431887
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje